BioGaia AB (publ)

PNK: BIOGY · Real-Time Price · USD
10.81
0.00 (0.00%)
At close: Apr 23, 2025, 9:38 AM

Company Description

BioGaia AB (publ) develops, markets, and sells probiotic products with documented health benefits worldwide.

It operates through three segments: Pediatrics, Adult Health, and Other.

The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula.

The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee's dairy product.

The Other segment provides packaging solutions.

The company offers its products in the areas of infantile colic and digestive health in children; antibiotic-associated and acute diarrhoea; gingivitis; periodontal disease; general health; Helicobacter pylori–the gastric ulcer bacterium; and low bone density.

It offers its products under the BioGaia brand name.

BioGaia AB (publ) was founded in 1990 and is headquartered in Stockholm, Sweden.

BioGaia AB (publ)
BioGaia AB (publ) logo
Country SE
IPO Date Jan 8, 2021
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 225
CEO Theresa P. Agnew

Contact Details

Address:
Kungsbroplan 3
Stockholm,
SE
Website https://www.biogaia.com

Stock Details

Ticker Symbol BIOGY
Exchange PNK
Fiscal Year n/a
Reporting Currency USD
CIK Code 0001572957
CUSIP Number 09072J102
ISIN Number US09072J1025
Employer ID 00-0000000
SIC Code

Key Executives

Name Position
Theresa P. Agnew Chief Executive Officer & President
Alexander Kotsinas M.Sc. (Eng.). Executive Vice President & Chief Financial Officer
Caroline Mofors Chief Legal Officer
Linda Hagglund Chief Marketing Officer
Ludvig Milesson Chief Operating Officer
Angelika Kjelldorff Chief HR Officer
Gianfranco Grompone Chief Scientific Officer and Vice President of Research & Development
Jonathan Gromark Sustainability Manager
Peter Rothschild M.Sc. Econ., MBA Founder & Chairman
Sebastian Heimfors Vice President & Chief Commercial Officer

Latest SEC Filings

Date Type Title
May 26, 2022 F-6 POS Filing
May 23, 2022 F-6 POS Filing
May 18, 2022 F-6 POS Filing
Apr 01, 2021 F-6EF Filing
Jun 30, 2017 F-6EF Filing
Mar 27, 2013 F-6EF Filing